Pfizer seeks U.S. authorization for vaccine booster retooled for Omicron | Reuters
Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine booster retooled to target the Omicron variant, and would have doses available to ship immediately after regulatory clearance.